Carbohydrate scaffolds as glycosyltransferase inhibitors with in vivo antibacterial activity
Open Access
- 21 July 2015
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 6 (1) , 7719
Abstract
The rapid rise of multi-drug-resistant bacteria is a global healthcare crisis, and new antibiotics are urgently required, especially those with modes of action that have low-resistance potential. One promising lead is the liposaccharide antibiotic moenomycin that inhibits bacterial glycosyltransferases, which are essential for peptidoglycan polymerization, while displaying a low rate of resistance. Unfortunately, the lipophilicity of moenomycin leads to unfavourable pharmacokinetic properties that render it unsuitable for systemic administration. In this study, we show that using moenomycin and other glycosyltransferase inhibitors as templates, we were able to synthesize compound libraries based on novel pyranose scaffold chemistry, with moenomycin-like activity, but with improved drug-like properties. The novel compounds exhibit in vitro inhibition comparable to moenomycin, with low toxicity and good efficacy in several in vivo models of infection. This approach based on non-planar carbohydrate scaffolds provides a new opportunity to develop new antibiotics with low propensity for resistance induction.Keywords
This publication has 64 references indexed in Scilit:
- Peptidoglycan Glycosyltransferase Substrate Mimics as Templates for the Design of New Antibacterial DrugsFrontiers in Immunology, 2013
- Crystal structure of Staphylococcus aureus transglycosylase in complex with a lipid II analog and elucidation of peptidoglycan synthesis mechanismProceedings of the National Academy of Sciences, 2012
- The rise of the Enterococcus: beyond vancomycin resistanceNature Reviews Microbiology, 2012
- Moenomycin family antibiotics: chemical synthesis, biosynthesis, and biological activityNatural Product Reports, 2010
- Functional and Structural Analysis of a Key Region of the Cell Wall Inhibitor MoenomycinACS Chemical Biology, 2010
- Genetic factors that influence moenomycin production in streptomycetesJournal of Industrial Microbiology and Biotechnology, 2010
- Complete Characterization of the Seventeen Step Moenomycin Biosynthetic PathwayBiochemistry, 2009
- Crystal structure of the membrane-bound bifunctional transglycosylase PBP1b from Escherichia coliProceedings of the National Academy of Sciences, 2009
- Crystal structure of a peptidoglycan glycosyltransferase suggests a model for processive glycan chain synthesisProceedings of the National Academy of Sciences, 2007
- Mechanism of Interaction of Different Classes of Cationic Antimicrobial Peptides with Planar Bilayers and with the Cytoplasmic Membrane ofEscherichia coliBiochemistry, 1999